Uncle Sam’s Secret Inventions: License a Health Breakthrough Today!
Published Date: 6/16/2025
Notice
Summary
The U.S. Government owns a cool new invention and is ready to share it with businesses and innovators who want to license it and bring it to market fast. This means anyone interested can jump in, help improve public health, and possibly make some money. Act quickly to grab this chance and turn government research into real-world solutions!
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Government Invention Available for Licensing
The U.S. Government owns an invention that is available for licensing so businesses and innovators can commercialize federally funded research to benefit public health. If you are a business owner or entrepreneur, you can apply to license the invention and potentially bring a product to market and earn revenue.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10310 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meeting
The National Institute on Deafness and Other Communication Disorders is holding a private virtual meeting on July 20, 2026, to review grant applications. This meeting affects researchers seeking funding for projects related to hearing and communication disorders. No public access is allowed to protect sensitive information, and the decisions could impact future research funding.
2026-10231 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings on June 25, 2026, to review and evaluate important grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. Researchers applying for grants should note the date, as these reviews impact who gets money for their work.
2026-10175 — Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a private virtual meeting on June 9, 2026, to review grant applications about infectious diseases and immunology. This closed session protects sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as this review impacts funding decisions.
2026-09947 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting health science projects. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10022 — Submission for OMB Review; 30-Day Comment Request; Early Career Reviewer Program Online Application and Vetting System (Center for Scientific Review)
The NIH wants your thoughts on their Early Career Reviewer Program’s new online application and review system. This affects early career scientists applying to review research, making the process smoother and digital. You’ve got 30 days to share your feedback—no cost changes, just a smarter way to apply!
2026-10021 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate grant applications related to health and cancer research. These meetings are private to protect sensitive information and personal privacy. Researchers applying for grants and NIH staff are the main players, with no direct cost changes announced but important deadlines to keep in mind.
Previous / Next Documents
Previous: 2025-10853 — Information Collection Being Reviewed by the Federal Communications Commission
The FCC is asking the public and other agencies to help review and improve its paperwork to make it easier and less time-consuming. This affects anyone who fills out FCC forms, especially small businesses with fewer than 25 employees. They want your feedback now to keep things clear, useful, and fair—so get ready to share your thoughts before the deadline!
Next: 2025-10855 — Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Biologic License Application (BLA) 761440 for Belantamab Mafodotin
The FDA is holding a public meeting to talk about a new cancer drug called Belantamab Mafodotin. They want advice from experts and feedback from the public before deciding if the drug should be approved. This could affect patients and doctors soon, so everyone’s input matters!